HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs

EMBO Journal

Volumn 24, Issue 10, 2005, Pages 1821-1830

  Longworth, Michelle S ^a   Wilson, Regina ^a   Laimins, Laimonis A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

E2F2; E7; Histone deacetylase; Human papillomavirus

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; PROTEIN E7; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F2; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 31; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; KERATINOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION; WART VIRUS; WESTERN BLOTTING;

E2F2 TRANSCRIPTION FACTOR; EPITHELIAL CELLS; HISTONE DEACETYLASES; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 20044366070     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600651     Document Type: Article

References (29)

1. Aslanian A, Iaquinta PJ, Verona R, Lees JA (2004) Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev 18: 1413-1422
2. Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T (1999) The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J 18: 2449-2458
3. Cheng S, Schmidt-Grimminger D, Murant T, Broker T, Chow L (1995) Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev 9: 2335-2349
4. Ciccolini F, Di Pasquale G, Carlotti F, Crawford L, Tommasino M (1994) Functional studies of E7 proteins from different HPV types. Oncogene 9: 2633-2638
5. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370: 737-749
6. Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma vims-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937
7. Edmonds C, Vousden KH (1989) A point mutational analysis of human papillomavirus type 16 E7 protein. J Virol 63: 2650-2656
8. Fehrmann F, Klumpp DJ, Laimins LA (2003) Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol 77: 2819-2831
9. Fehrmann F, Laimins LA (2004) Human papillomavirus type 31 life cycle: methods for study using tissue culture models. Methods Mol Biol 292: 317-330
10. Ginsberg D (2004) E2F3-a novel repressor of the ARF/p53 pathway. Dev Cell 6: 742-743
11. Greenfield I, Nickerson J, Penman S, Stanley M (1991) Human papillomavirus 16 E7 protein is associated with the nuclear matrix. Proc Natl Acad Sci USA 88: 11217-11221
12. Guenther MG, Barak O, Lazar MA (2001) The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21: 6091-6101
13. Halbert CL, Demers GW, Galloway DA (1991) The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol 65: 473-478
14. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE (1997) Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89: 341-347
15. Helt AM, Galloway DA (2001) Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J Virol 75: 6737-6747
16. Hummel M, Hudson JB, Laimins LA (1992) Differentiation-induced and constitutive transcription of human papillomavirus type 31 b in cell lines containing viral episomes. J Virol 66: 6070-6080
17. Li FX, Zhu JW, Tessem JS, Beilke J, Varella-Garcia M, Jensen J, Hogan CJ, DeGregori J (2003) The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc Natl Acad Sci USA 100: 12935-12940
18. Longworth MS, Laimins LA (2004) The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol 78: 3533-3541
19. Makris C, Voisin L, Giasson E, Tudan C, Kaplan DR, Meloche S (2002) The Rb-family protein p107 inhibits translation by a PDK1-dependent mechanism. Oncogene 21: 7891-7896
20. Marzio G, Wagener C, Gutierrez MI, Cartwright P, Helin K, Giacca M (2000) E2F family members are differentially regulated by reversible acetylation. J Biol Chem 275: 10887-10892
21. Maser RS, Mirzoeva OK, Wells J, Olivares H, Williams BR, Zinkel RA, Farnham PJ, Petrini JH (2001) Mre11 complex Sand DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol 21: 6006-6016
22. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417-4421
23. Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716
24. Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ (2000) Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 275: 6764-6769
25. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16: 245-256
26. Ruesch MN, Laimins LA (1998) Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium. Virology 250: 19-29
27. Swindle CS, Zou N, Van Tine BA, Shaw GM, Engler JA, Chow LT (1999) Human papillomavirus DNA replication compartments in a transient DNA replication system. J Virol 73: 1001-1009
28. Takahashi Y, Rayman JB, Dynlacht BD (2000) Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14: 804-816
29. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19